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Abstract
Summary There is increasing need to understand patient out-
comes in osteoporosis. This article discusses that fracture in
osteoporosis can lead to a cycle of impairment, driven by com-
plex psychosocial factors, having a profound impact on physical
function/activity which accumulates over time. More informa-
tion is required on how treatments impact physical function.
Introduction There is increasing need to understand patient-
centred outcomes in osteoporosis (OP) clinical research and
management. This multi-method paper provides insight on the
effect of OP on patients’ physical function and everyday activity.
Methods Data were collected from three sources: (1) targeted
literature review on OP and physical function, conducted in
MEDLINE, Embase and PsycINFO; (2) secondary thematic
analysis of transcripts from patient interviews, conducted to
develop a patient-reported outcome instrument. Transcripts
were re-coded to focus on OP impact on daily activities and
physical function for those with and without fracture history;
and (3) discussions of the literature review and secondary
qualitative analysis results with three clinical experts to review
and interpret the importance and implications of the findings.
Results Results suggest that OP, particularly with fracture, can
have profound impacts on physical function/activity. These
impacts accumulate over time through a cycle of impairment,
as fracture leads to longer term detriments in physical func-
tion, including loss of muscle, activity avoidance and reduced
physical capacity, which in turn leads to greater risk of fracture
and potential for further physical restrictions. The cycle of
impairment is complex, as other physical, psychosocial and
treatment-related factors, such as comorbidities, fears and be-
liefs about physical activity and fracture risk influence phys-
ical function and everyday activity.
Conclusion More information on how treatments impact
physical function would benefit healthcare professionals and
persons with OP inmaking treatment decisions and improving
treatment compliance/persistence, as these impacts may be
more salient to patients than fracture incidence.
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Osteoporosis (OP) is a growing public health concern and affects
more than 200 million people worldwide [1]. Individuals living
with OP are at greater risk of experiencing a fragility fracture. In
developed countries, lifetime risk for a wrist, hip or vertebral
fracture has been estimated at 30–40% [2]. For individuals aged
50 years and over, approximately one in two women and up to
one in four men will experience an osteoporotic fracture [3].
Worldwide, the disease has been reported to account for more
than 8.9 million fractures annually [4]. Due to the importance of
fracture in the progression of OP, clinical trials investigating
novel therapeutic agents have focused on endpoints relating to
bone health and fracture incidence. The US Food and Drug
Administration (FDA) approval requirements for new therapies
emphasise reducing the risk of vertebral fracture along with
maximising drug safety [5].
While fracture incidence is clearly of clinical importance in
OP, the extent to which it sufficiently captures outcomes that are
patient-centred remains unclear, particularly given the potential
impact of fracture on patients’ everyday lives such as mobility
and other types of physical activity. Initially OP is considered
asymptomatic, but this situation can change dramatically once a
fracture has occurred. Fractures can result in reduced mobility
and physical function. They can also result in chronic pain or
affect the ability to self-care. Fractures can also have long-term
consequences on physical function and greatly affect patients’
health-related quality of life (HRQL) [6–9].
The importance of patient-centred outcomes when assessing
new treatments is being recognised across a range of therapeutic
areas. The FDA, along with the Patient-Centered Outcomes
Research Institute (PCORI), has published guidance on the use
of patient-reported outcomes (PROs) in product labelling and
clinical research, respectively, and highlighted their value [10,
11]. A greater awareness of patient-centred outcomes has the
potential to guide treatment decisions and encourage more
patient-focused prescribing. Nevertheless, PROs are assessed
infrequently in OP clinical trials and when included, rarely in-
volve more than a small subset of subjects. As a result, any
opportunity to detect a meaningful change in PROs related to
treatment is limited. Furthermore, in instances where benefits in
PROs have been detected during well-controlled trials [12–15],
these outcomes have been omitted from product labels. As such,
there is an increasing need to understand and capture patient-
centred outcomes in OP. The objective of this paper is to use
evidence and patient perspectives to provide insight on the effect
of OP on patients’ physical function.
Methods
A multi-method approach was used to consolidate our under-
standing of physical function in OP. A systematic search and
narrative literature review was conducted, to seek and sum-
marise published evidence related to daily activities requiring
physical function in OP. In addition, a secondary qualitative
analysis of patient data, originally collected for the develop-
ment of a PRO instrument, was performed. Finally, input was
sought from key clinical thought leaders specialising in OP, to
review, interpret and add to the findings of the literature re-
view and interview analysis. The final result is a comprehen-
sive perspective on the impact of OP and osteoporotic fragility
fractures on physical function or performance.
Literature review
The literature search was designed to identify publications
describing the impact of OP on daily activities and physical
function. The search was conducted in MEDLINE and
Embase using the web-based platform Ovid. Developing the
search strategy was an iterative process with the initial use of
draft searches, checking the outcome by reviewing a propor-
tion of resulting abstracts for relevance and updating the
search terms to improve the relevance of results. The initial
search strategy included terms focused on OP and daily activ-
ities and function and was limited to more recent publications
(published within 8 years) and those including patients aged
≥45 years. A further search strategy was developed to specif-
ically identify qualitative studies that discussed the impact of
OP on physical function and daily living from a patient’s
perspective and was conducted in PsycINFO, in addition to
MEDLINE and Embase. The final search terms are presented
as a supplementary appendix. Abstracts were reviewed and
those deemed relevant were selected for full review. Articles
were deemed relevant if they reported on the impact of OP on
physical function/daily activities or the relationship between
physical function and fracture occurrence.
Secondary qualitative analysis of interview transcripts
Given the lack of existing literature around OP and physical
function from the patient perspective, a secondary thematic
analysis of data collected during interviews with people with
OP was performed. These interviews were originally conduct-
ed during the development of the Osteoporosis Assessment
Questionnaire-Physical Function (OPAQ-PF) questionnaire, a
PRO instrument developed to evaluate osteoporosis treatment
effectiveness [16]. During the instrument development pro-
cess, 39 people with OP were recruited from three clinical
centres in the USA, and concept elicitation and cognitive
debriefing interviews were conducted. All patients were
consented to the study, all interviews were conducted using
a semistructured interview guide in a face-to-face setting by an
experienced, trained interviewer and all were audio-recorded
and transcribed. The sample was all female with a mean age of
70 years (standard deviation [SD] = 10.35), and the majority
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were white (n = 34). All participants had been living with OP
for at least 1 year, and the mean disease duration was 7.2 years
(SD = 2.16). The majority of participants (n = 27) had expe-
rienced one or more osteoporotic fractures, with most having
had a single fracture (n = 22). The maximum number of frac-
tures experienced by a single participant was three. Fractures
had occurred between 3 and 140 months (11.6 years) prior to
being interviewed, with a mean time since fracture of
31.6 months (SD = 37.9). Participants with comorbidities
were not excluded from the sample in order to reflect the wider
OP population, as comorbid conditions are very common in
this population. However, this made it more difficult in some
cases to attribute impact on physical function to OP.
Comorbidities included osteoarthritis, rheumatoid arthritis, di-
abetes, asthma and chronic obstructive pulmonary disease
(COPD).
The secondary, thematic analysis of the interview data
was conducted in two phases; the first was at a broad
level to isolate relevant sections of the transcripts (i.e.,
those that focus on physical impacts of OP including
any discussion of physical functioning, physical activities
of daily living and the importance to patients of this type
of impact). Data analyses were conducted by two of the
authors (SS and CP) using MAXQDA 10, a qualitative
analysis software tool that facilitates systematic coding.
The two researchers (SS and CP) familiarised themselves
with the data and generated initial codes on the same two
transcripts. The initial codes were then compared, to
check for consistency, ensuring that both researchers were
including the same/very similar sections for further cod-
ing. The following stage of analysis involved coding the
relevant sections in greater detail that related to OP im-
pact on daily activities and physical function, the relative
experience and impact of patients with osteoporotic frac-
ture versus those who had not had osteoporotic fracture,
and the importance of these impacts to patients. The codes
identified during analysis were then grouped into themes
which were then reviewed and defined by the researchers
(SS and CP).
Review by clinical experts
Results from the literature review and secondary qualita-
tive analysis of interview transcripts were reviewed and
discussed with three clinical experts (LG, SR and DTG)
specialising in OP with extensive experience in investigat-
ing HRQL, medication compliance and persistence, phys-
ical activity, exercise recommendations and OP interven-
tions, through academic research, clinical practice or pa-
tient advocacy. Discussion took place during two in-depth
telephone conferences, held on the 8th and 23rd May
2014. Specific questions considered in these discussions
are presented in Table 1. Further input was sought through
an iterative and collaborative process of developing a
written summary of the discussions.
The information gathered in the literature review, second-
ary qualitative analysis of patient interview transcripts and
clinical input were consolidated and grouped by common
themes. Quotes from patient interview transcripts are included
to illustrate points from the perspective of people living with
OP. Each quote is followed by details of the individual to link
to the original data source (identification number) and provide
contextual information to aid interpretation (their age, the
number and location of fractures they have experienced, the
length of time since fracture(s) in months and any comorbid
conditions). Where relevant, the interviewer’s questions are
stated in italics.
Results
The examination of findings from the three data sources
suggests that overall, osteoporosis and osteoporotic fragil-
ity fractures can have a substantial impact on physical
function and this impact accumulates over time, through
a cycle of physical impairment, limitation and restriction.
This cycle of impairment is illustrated in Fig. 1 and depicts
the relationships among fracture, physical impairment, ac-
tivity restrictions and loss of bone/muscle strength over
time. It also documents the role of added complexities,
such as psychological and social factors and comorbid con-
ditions, in the further limitation of physical function and
everyday activity. Using the cycle of impairment as a
framework, results on the impact of OP and fracture on
physical function are detailed in the following sections
Table 1 Specific questions considered during discussions with OP
experts
•What effect does decline in physical function have on the daily lives of
people with OP?
• What is the value of improvement of physical function and ability to
perform daily activities requiring physical function to people with OP?
• What is the value of maintaining physical function and the ability to
perform daily activities requiring physical function to people with OP?
•How strong is the relationship between fracture occurrence and ability to
perform daily activities requiring physical function in OP? To what
extent does this vary between individuals?
• How much of the decline in physical function experienced by people
with OP is not explained by fracture occurrence?
• What other factors affect physical function and performance of daily
activities requiring physical function in people with OP?
•What are the unmet needs or gaps in current treatment in relation to the
effect of OP on peoples’ performance of daily activities requiring
physical function?
• What is the added value of evaluating physical function to inform
treatment effectiveness? What does measurement of physical function
capture that is not already explained by fracture occurrence?
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based on the findings from the literature, secondary analy-
sis of patient interview data and clinical expert discussions.
Physical function in OP and reduced activity
Physical function is an individual’s ability to perform physical
tasks and activities and is known to be affected in OP, among
those both with and without fracture [16]. Impairment of phys-
ical function in OP manifests as an inability to complete regular,
daily activities requiring physical movement and strength.
Affected activities include those requiring mobility (such as
walking, climbing stairs), certain physical positions (such as
sitting, picking things up from the floor) and physical transfers
(such as getting in or out of a chair, on or off the toilet).
B…taking care of personal hygiene, it just—you just
have to move a little slower and take your time because
you’re limited in your range of motion… if you’re
washing your back or something or trying to wash your
hair, you’re limited, so it seems like it takes forever and
therefore, you get, kind of, tired^ [R1P3, 55 years, one
fracture, 36 months since fracture.]
People with OP report being unable to carry out these ac-
tivities unaided even after fractures have healed, and often
require help to carry out basic daily activities [16].
Numerous factors are known to influence physical function
in OP, most notably the occurrence of fractures and the loss of
bone and muscle strength.
Fracture occurrence
The occurrence of fracture(s) is known to cause increasing
limitations in physical function for people with OP. Various
tools (e.g. the Continuous Scale Physical Functional
Performance [CS-PFP] and the Physical Performance Test
[PPT]) are available to assess the usual functional movements
in older adults [17, 18]. Physical performance is measured
during standardised functional tasks in terms of time taken
to complete a task, weight lifted and/or distance covered.
The Safe Functional Motion Test (SFM) [19] builds on the
constructs and tasks of the CS-PFP and PPTand is specifically
designed for use in people with osteoporosis. The SFM quan-
tifies physical function in terms of body mechanics and move-
ment strategies used to perform everyday activities [19].
Using the SFM, it has been shown that those with hip or
vertebral fracture and fall history are more likely to have poor
performance and physical function when completing every-
day tasks than those with no history of fracture or falls [20].
Analysis of an osteoporosis clinic database indicated that pa-
tients with fewer limitations in physical performance accord-
ing to SFM scores were less likely to present with vertebral
compression fracture (odds ratio [OR] 0.89; p = 0.036), prev-
alent hip fracture (OR = 0.77; p = 0.004), or a history of
injurious fall (OR = 0.80; p = 0.003) after adjusting for other
important covariates [20].
Outcomes after a fracture may be worse among older peo-
ple for whom poor physical health is likely to be associated
with social disconnectedness and perceived isolation [21].
The influence of fracture on physical function and other
Fig. 1 The cycle of impairment
and fracture in OP
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aspects of individual well-being is likely to vary depending on
(i) fracture location and (ii) the number of fractures
experienced.
Fracture location
Fractures of the wrist or vertebra are perceived to result in
fewer physical impairments or restrictions than hip fracture
during the acute stages. The influence of fracture on physical
function will also depend upon the degree of pain and recov-
ery trajectory associated with fractures, which will vary by
fracture type and severity. Wrist fracture may still affect daily
activities requiring physical function, particularly due to re-
duced grip strength during and after healing. The effects of
spine fracture on physical function may be quite variable,
depending on the number, severity and chronicity of frac-
ture(s), or the presence of pain. A hip fracture is immediately
debilitating, limits mobility and results in hospitalisation, with
physical function impairments that can often persist long after
the fracture. Importantly, mobility impairments due to hip
fracture may restrict participation in life roles or the capacity
to live independently.
BI was on my feet for three hours making dinner and I
love cooking, but since I’m so slow anymore, you know,
it took an extra hour than it normally would and my
back and my upper hips were feeling it. They were
hurting^ [P20, 57 years, two fractures at the hip and
femoral shaft, timing unknown, comorbid osteoarthritis
and diabetes]
B…I’d kind of get a little bit too tired and it starts hurting
my wrists and stuff when I dig stuff or do things heavily,
you know^ [P17, 74 years, two fractures at the forearm
and foot, 8 months since both fractures, comorbid
osteoarthritis]
The relationship between fractures and physical function is
particularly important in the case of asymptomatic vertebral
fractures, which do not cause clinical manifestations, such as
pain or obvious limitation. People with asymptomatic frac-
tures are unlikely to seek medical advice and often continue
with their lives, accommodating and adapting to their reduced
strength or speed but also restricting their physical activity, for
an extended period of time. Vertebral fractures are globally
under-recognised, under-reported and under-managed in peo-
ple with OP [22]. Furthermore, a single vertebral fracture in-
creases the risk of a future fracture by five and doubles the risk
of a future hip fracture [23], with asymptomatic fractures car-
rying the same risk as those that have been diagnosed.
Number of fracturesThe number of fractures the personwith
OP has experienced is negatively correlated with physical
function and HRQL [6–9]. Many studies use the presence of
one or more fractures as a meaningful cut-off to predict lower
HRQL, but it is likely that physical and psychological impair-
ments increase with increasing number of fractures [14, 24].
Individuals with multiple fractures may experience: reduced
speed in performing activities requiring physical function, re-
duced strength, hyperkyphotic posture and suboptimal verte-
bral alignment, and reduced mobility [25, 26].
BI couldn’t do anything with the—at my Pilates
class ‘cause, you know, my foot hurt. I couldn’t
put my foot to the actual ground, so if you—without
the shoe, there was no way I could walk, so it was
pretty painful, so it affected everything^. [P4,
60 years, two fractures at the shoulder and toe, 22
and 6 months since fractures]
In addition, outcomes such as hyperkyphosis also lead to
increased mortality and a higher risk of future fractures [27,
28].Multiple fractures affect biomechanics, HRQL, fear, body
image as well as physical function. People who have experi-
enced only a single vertebral fracture (and no other osteopo-
rotic fractures), commonly report little effect on daily
activities requiring physical function. However, this can
change significantly once an individual has experienced two
or more fractures, particularly where they cause pain or
hyperkyphosis.
Loss of bone and muscle strength
Loss of bone and muscle strength are often experienced to-
gether, especially in older individuals [29, 30]. Research has
shown an association between muscle strength and bone
health [30–32], with the various facets of muscle strength
(e.g. mass, function and performance) generally showing a
positive relationship with bone mass or density. Muscle weak-
ness experienced by those with OP may also be due to phys-
ical de-conditioning from reduced activity levels, where peo-
ple with OP stop or severely restrict daily activities and other
exercise. The degree of muscle loss can increase following
fracture, particularly if the fracture results in pain, which can
limit activity, such as after a vertebral fracture, or after long
period of inactivity, such as after a hip fracture.
BDoes my fracture have an impact onmy ability to climb
steps or stairs, and as I said before, some of it comes
directly from pain that might be caused from the frac-
ture, but a lot of it has to come from the effects on my
body since the fracture that if you’re not staying in
shape, then you’re losing endurance, you’re losing mus-
cles and you’re not able to complete some simple tasks
just because of that. So it’s, kind of, a secondary effect
from the fracture^. [P21, 59 years, one fracture at the
spine, 11 months since fracture]
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The term sarcopenia has been used to define various as-
pects of muscle health loss, but more recently, it has been
defined as a loss of muscle mass and function [29]. OP and
sarcopenia are common in older age and associated with sig-
nificant morbidity and mortality [29]. When people with OP
also demonstrate the criteria for sarcopenia, they and those
around them can become concerned about their ability to per-
form daily activities safely and without assistance. Fractures
or weakness (perceived or real by person with OP or family/
caregivers) may lead to activity avoidance or limitation.
Psychological and social factors related to physical
impairment/reduced activity
Individuals with OP may experience fear (particularly of fall-
ing or fracture), depression, and other psychological outcomes.
These consequences are often underestimated when consider-
ing the overall burden of OP [33]. The psychological effect of
an OP diagnosis can be increased where people anticipate
change in body shape and physical decline. Due to the hered-
itary and age-related aspects of OP, people diagnosed with OP
may already have observed hyperkyphosis, other changes in
body shape or decline following fractures in their relatives or
peers, even where this may not have been confirmed by OP
diagnosis. Psychological outcomes can add to limitations in
physical function to reduce social activity, interaction and par-
ticipation. Social and disease-specific support groups may
have a positive impact on psychological and social outcomes
in OP [34].
Fear/anxiety
People with OP report caution and fear of fracture during daily
activities requiring physical function and physical activity
[35]. For example, a quality of life survey of 234 female pa-
tients with persistent pain due to vertebral fracture found that
fear of more fractures or falling was correlated to the domains
of physical limitations (r = 0.43; p < 0.001), activities of daily
living (r = 0.44; p < 0.001) and leisure (r = 0.25; p < 0.05)
[35]. Fear can be further exacerbated by reduced muscle
strength and a lack of confidence in strength to safely perform
certain activities. As a result, activities are completed more
slowly, less often or avoided altogether.
BYeah, I stopped riding my bike too ‘cause I’m afraid of
falling^ [P11, 74 years, one fracture at the ribs,
12 months since fracture, comorbid osteoarthritis]
B…I don’t accomplish all the things I wanted to do and I
find myself sitting more. And I did go to water aerobics,
but now I told the Physical Therapist that if I go to water
aerobics now, if I drive over there, then when I get in the
pool, the steps are very steep, the steps are big and I’m
afraid I can’t get out and I don’t have the strength to pull
myself out of the pool. So I mean, it limits me to so
many things that I did before^. [P18, 84 years, comorbid
osteoarthritis]
Fear of falling and impaired physical performance are also
related to intensity of back pain in people with OP, irrespective
of vertebral fracture and fall history [36]. Other psychosocial
consequences of OP such as frustration and anxiety can also
contribute to reduced activity levels, whereas regular exercise
can actually reduce symptoms of anxiety [37].
Depression
Many people with an osteoporotic fracture experience either
situational or chronic depression, and regular pain is known to
be an important factor in psychological well-being [38].
Preliminary data from the CORE study indicated a high prev-
alence of depression (69 %) in osteoporotic-fragile elderly
females (mean age 85 years) [39]. A large nationwide
population-based study based on the Taiwan Longitudinal
Health Insurance Database found that the incidences of major
depression were 1.2 % in those hospitalised for a femoral neck
fracture and 0.7 % in those in the non-fracture comparison
group (hazard ratio [HR] 1.82; 95 % confidence interval
[CI] 1.30, 2.53; p = 0.001) [40].
Depression can reduce both physical energy and psycho-
logical motivation to carry out daily activities requiring phys-
ical function. Therefore, it may prevent people from increas-
ing their physical function when advised to do so. Depression
can also lead to social isolation and affect cognitive abilities,
which can result in restricted participation in social activities
or life roles [39–42].
Altered body image
OP and fracture(s) can cause a change in body image which
can have a significant effect on physical and social function-
ing. Older adults can lose up to 1 inch of height as they age,
but the effect of osteoporotic fractures on height loss and
deformity can be substantially worse. Vertebral fractures
change both the shape and alignment of the lumbar and
thoracic spine, leading to hyperkyphosis or Bdowager’s
hump^. Other changes can include a constriction of internal
organs, protruding abdomen, forward head position and flat-
tening of the lordosis or curve in the lower back. These sig-
nificant changes substantially alter an individual’s appearance
and result in ill-fitting clothes.
The issue of self-image and clothingwas found to be highly
important during theChoices™ patient education programme
for OP [43, 44]. In addition, the need for a supportive device
such as a cane or walker further enforces an individual’s self-
consciousness of impairment. A negative body image is likely
to influence an individual’s willingness to participate in social
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activities and hence lead to social isolation. Furthermore, peo-
ple can be unwilling to use recommended mobility aids in
order to avoid negative perceptions from others. By not using
such aids, people can increase their risk of falls and fractures
thus leading to a possible decrease in physical function.
Low self-esteem
Clinical experience suggests that the low self-esteem experi-
enced by people with OP can result from a number of factors,
which include an increasing inability to continue, perform or
engage in previously normal activities. Decrements in physi-
cal function often result in a shift in family or societal roles.
For example, women may be told or feel they are no longer
able to pick up more than 10 or 15 lb, leading to a change in
their grand-parenting role and the inability to interact with a
grandchild.
BBefore I was diagnosed, I would pick upmy grandkids,
hold them and were 50, 60 pounds… since the diagno-
sis, I’m just much more careful. I’m like, ‘No, I’m not
going to do that’, you know .^ [P6, 57 years]
Other functional limitations may lead to a reduced ability to
complete previous volunteer or work roles. In addition, people
with OP may experience reduced self-worth when they com-
pare themselves with others their age that are able to continue
to carry out these roles. Low self-esteem can also be linked to
body image and people with OP often worry about how they
are seen by others, particularly when hyperkyphosis leads to
visible changes in physical appearance. Low self-esteem can
also be caused by self-blame for having the condition; for
example, feeling they may have done something to cause their
OP, such as not eating a healthy diet or exercising enough.
Comorbid conditions
Comorbid conditions are common and variable in the OP
population as was found in the interview sample, and include
other musculoskeletal conditions and autoimmune disorders
[45]. The presence of comorbidities can affect the ability of
people with OP to complete daily activities requiring physical
function. Any comorbid condition, especially arthritis, can
exaggerate the effects of OP, potentially making daily activi-
ties requiring physical function harder.
BI mean, as you get older with this bending, sometimes
I’ll bend down and I think, oh, I can’t get up, I mean,
you know, yes, so there is some problems, but I don’t
know if it’s related to osteoporosis or just the arthritis
and aging, you know, so it’s hard to know .^ [P11,
74 years, 1 fracture at the ribs, 12 months since fracture,
comorbid osteoarthritis]
Some comorbidities can increase the risk of fracture, par-
ticularly when the risk of falls is increased [46]. Symptoms
such as neuropathy, orthostatic hypotension and dizziness
which increase the risk of falling can also predict the risk of
fracture and decline in physical activity. In addition, comor-
bidities which cause pain, for example rheumatoid arthritis,
can alter peoples’ level of physical activity and change the
way they carry out daily activities requiring physical function,
leading to an increased risk of fracture. As a result, assessing
functional impairment caused by OP can be difficult when
other chronic conditions are present and this was evident in
the interviews. Osteoarthritis and OP are often confused by
patients, who may not understand the difference between
these two conditions or what disease caused which symptoms.
BThere isn’t a day that I don’t feel the osteoporosis inmy
hands, in my back, in my legs, in my toes and, you
know, whether I’m bending, or whether I’m walking,
or whether I’m stepping down, getting off the bed, going
to the bathroom, standing back up, even going- sitting
on the john…^ [P13, 82 years, comorbid osteoarthritis]
Beliefs about physical activity and fracture
Perceptions and beliefs around physical activity are important
influences of physical function. If people with OP are not used
to being physically active or undertaking exercise, then a di-
agnosis of OPmay not change this, even if advice on the types
and amount of exercise recommended is provided. Some peo-
ple with OP may choose to become inactive as a result of the
diagnosis because of an increased fear of falling or fracture
and increased fear may make it difficult to engage some peo-
ple with OP in exercise programs.
BWell I’m supposed to do a lot of walking, which I know
I can do for osteoporosis, but the sidewalk is uneven and
it’s dangerous. I have to be careful. I have to use a
walker where I normally wouldn’t^ [P10, 61 years, co-
morbid Parkinson’s disease]
For those unused to being physically active before OP,
cultural factors and other learned behaviour can represent ad-
ditional barriers to adopting a more physically active lifestyle
[47]. Conversely, people who exercise regularly and consider
themselves Bhealthy^ can incorrectly attribute low-energy
fractures to external events rather than bone health, believing
that their preventative behaviours or absence of other risk
factors means they are at low risk of future fracture [48, 49].
Perceptions around the consequences of fracture are impor-
tant. Research has shown that women, who blame fractures on
external events and do not attribute them to bone health, can
experience long-term consequences for personal health, social
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and financial implications, which are often underestimated
[50].
In individuals with osteoporosis, differences in levels of
self-efficacy (the belief that one can carry out a behaviour)
may have personal health, social and financial implications.
Self-efficacy may impact an individual’s willingness to adopt
a more active lifestyle, to eat healthily or up take of treatment
for osteoporosis. This impact should be a consideration for
researchers, as exemplified in a recent Maternal Vitamin D
Osteoporosis Study (MAVIDOS) in which mothers with
higher self-efficacy were less likely to experience practical
problems taking vitamin D during the trial [51].
Prescribed treatment and advice from healthcare
professionals
Exercise advice from physicians and other providers without
training in physical activity is often too general to be useful.
For example, a common recommendation made by physicians
to people with OP is not to lift Banything heavier than a 5
pound bag of sugar .^
BTell me about how osteoporosis impacts you on a day-
to-day basis?
Hmmm. Well, it does—I am on restrictions now.
Okay and what are those restrictions?
It’s not lifting more than ten pounds^. [P14, 66 years,
one fracture at the spine, 7 months since fracture]
This kind of nonspecific general advice is not helpful to
many people with OP, who can experience a fracture when
completing activities that do not involve lifting heavy objects,
for example bending over to tie their shoes. In addition, people
with OP may be advised by their physicians to stop the leisure
activities that they enjoy and those which get them out of the
house and exercising. Golf, skiing, yoga and Pilates are forms
of physical activity that professionals often advise against be-
cause of concerns about increased risk of fracture. However,
applying advice to avoid certain activities is appropriate in
other instances, such as sit ups or abdominal curls or rotations,
as these and similar activities involve twisting of the spine or
Bflexion^ which may cause vertebral fractures [52]. However,
it is important to tailor advice according to risk, activity his-
tory and other factors, such as time since fracture or use of
osteoporosis medication. Further, one might consider that
placing restrictions is a disincentive to physical activity and
may create fear, whereas advice on how to move safely and
modify activities may provide an incentive to stay active. For
example, some people with osteoporosis (e.g. otherwise
healthy, but at moderate risk of future fracture) may simply
need to practice ‘spine sparing’ strategies and take efforts to
reduce fall risk [53].
Advice provided by physicians has influence beyond the
physical well-being of the patient, and ceasing participation in
leisure activities and hobbies is also likely to affect social and
psychological outcomes. People with OP have reported that
they view exercise as an important way of taking an active role
in their health and feel that being diagnosed with OP means
they are unable to participate in fun, socially engaging exer-
cise activities and are instead advised by healthcare profes-
sionals to undertake less enjoyable structured exercise pro-
grams. Multimodal exercise has been identified by experts
as a priority intervention in OP and shown to reduce pain
and improve quality of life in individuals with vertebral frac-
tures [53, 54].
Treatment compliance and persistence
Poor compliance and persistence with OP medication and
other interventions can result in increased fracture risk, pain
and subsequently further limitations in physical function.
Reasons for noncompliance and nonpersistence to therapy
include cost, inconvenience, safety issues and efficacy con-
cerns of osteoporosis medications. When patients are asked to
rank these attributes of OP medication, their age, education
level, income and experience of prior fractures have been
shown to have a significant effect on their treatment decision
[55]. Patient engagement and interest in treatment are a key
driver of compliance and persistence, and poor compliance
and persistence with OP medication have been shown to be
mostly due to deliberate choice rather than forgetfulness [56].
There is also little knowledge about the prevalence of primary
noncompliance and nonpersistence with these medications.
In OP, patient engagement in treatment can be especially
challenging if it involves increasing exercise beyond usual
levels, and this is particularly problematic in elderly individ-
uals. Long-term compliance and persistence with exercise in-
terventions among individuals with OP are variable and can
range from 39 to 95 % [57–59]. Older adults with OP report
not being interested in exercise, being in too much pain to
exercise and having a fear of falling [60].
Discussion
While capturing fracture incidence is well-recognised as im-
portant in the study and management of OP, there is an in-
creasing need to understand the physical impact of OP beyond
fracture to ensure patient-centred research and management.
The cycle of impairment presented here summarises how nu-
merous factors can contribute to an increasing limited physical
function in people with OP. Firstly, limiting activity can con-
tribute to loss of muscle and bone strength and subsequently
an increase in fracture risk. In turn, fracture occurrence can
result in pain, fear of falling or changes in alignment, which
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can limit the performance of daily activities requiring physical
function. Thus, a decrease in physical function can lead to an
accumulation of impairment and activity restrictions over
time.
Factors affecting outcomes across the physical, social and
psychological spectrums are interrelated, and further elucidat-
ing these interactions is important to understand the true con-
sequences of OP. The confounding effects of comorbidities
and poor treatment compliance and persistence also must not
be overlooked. This multifactorial picture of OP has important
implications for treatment, as only once we understand all the
factors that may influence an individual’s disease can we truly
provide efficacious treatment. Limitations in physical function
and restricted participation in society can occur gradually and
are influenced by a range of factors including pain, availability
of social support and the number of fractures. The situation
can be made worse where vertebral fractures are not diag-
nosed or where advice from healthcare professionals is not
based on validated assessment or sufficiently tailored to the
individual.
The results of this review support that patient-centred out-
comes are important to capture for evaluating treatment and
managing the condition, as they provide additional insight
into the impact of OP and fracture on the patient’s everyday
life and overall well-being, improvement in which are key
goals of treatment. Currently, few studies have examined the
effect of pharmacologic treatment on physical function out-
comes in OP, yet understanding the benefit of treatment in
terms of physical function and everyday life activity would
be valuable to inform physicians and help people with OP
understand these potential benefits when making treatment
decisions. This could, in turn, help to improve compliance
and persistence with treatment. In contrast, studies of exercise
often collect patient-centred outcomes [61]. However, it might
be advisable to agree on a core set of outcomes for future trials
to facilitate comparisons.
The findings of this review also provide insight on how
communication between healthcare professionals and people
with OP could be improved in terms of the information and
advice provided to patients related to physical function and
activity. Information and advice provided to people with OP
are an important factor in how they will respond and persist
with treatment. In order to improve these interactions, our
suggestion to clinicians and other healthcare professionals is
to provide clear, simple explanations about the physiology,
symptoms and potential impacts of OP on physical function
at diagnosis, as well as the possibility of social and psycho-
logical issues that may also affect physical function. Having
this greater awareness of the long-term consequences of OP in
terms of physical function, body shape and everyday activity
may encourage persons with OP to better comply and persist
with treatment, as these impacts may be more salient to pa-
tients than fracture. In addition, in order to minimise the
confusion around exercise recommendations, physicians
should provide evidence-based exercise guidelines rather than
generic advice to exercise, to walk or get more active, and
should make referrals to exercise advice from physical thera-
pists or exercise physiologists specialising in the treatment of
OP.
The findings suggest that further investigation and research
into certain areas related to OP and physical function would be
useful. One such area is further assessing the relationship be-
tween muscle and bone strength in OP and how they interact
when it comes to limitations in physical function and perfor-
mance. It may also be valuable to investigate further the rela-
tionship among reduced societal participation, physical func-
tion and psychological impact. In particular, this would enable
us to understand the possible effects of a reduction in societal
participation that can occur as a result of OP. We would also
suggest studies to evaluate the optimal way to engage people
with OP in an appropriate and effective exercise treatment
plan.
Limitations of this report should be acknowledged. With
regards to the literature review, a key limitation was the insuf-
ficient classification of sample characteristics and methods in
the selected publications. Most importantly, many publica-
tions failed to state whether the study participants had a con-
firmed diagnosis of OP, and others included mixed samples of
those with OP and/or those who had experienced fractures.
While some studies did make comparisons between OP pa-
tients with and without fractures, results were reported in
terms of greater impact among fracture subgroups, rather than
presenting results to describe the level of physical function
and life impact among OP patients with or without fracture.
The secondary qualitative analysis of interview transcripts
was limited by the original aim to develop a specific PRO
instrument. As a result, although problems relating to physical
function and other factors influencing OP-related impairment
were captured during the interviews, theywere rarely explored
in detail. Participants were not asked further questions regard-
ing why a specific activity was problematic or how they felt
about any limitations caused by their OP. Furthermore, in
cases where participants did not report limitations, it is unclear
whether they did not experience them or simply had not men-
tioned them during the interviews. In addition, many of the
participants had comorbidities that also could impact physical
function making it sometimes difficult to attribute an impact
on physical function or activity to OP versus a comorbid con-
dition. To address this limitation, input was sought from clin-
ical experts through a review process to confirm validity and
inform interpretation of the information reported.
In summary, OP and fracture can have a profound impact
on physical function and everyday activity, and this impact
accumulates over time through a cycle of impairment, as frac-
ture leads to longer term detriments in physical function, in-
cluding loss of muscle, activity avoidance and reduced
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physical capacity, which in turn leads to greater risk of fracture
and potentially further reductions in physical function. This
cycle of impairment is complex, as other physical, psychosocial
and treatment-related factors, such as comorbid conditions,
fears and beliefs about physical activity and risk of fracture
influence limitations in physical activity and everyday function.
More information on how treatments impact patients in terms of
physical function and everyday activity would benefit both
healthcare professionals and persons with OP in making treat-
ment decisions and improving overall outcomes. Furthermore,
informing patients about the potential long-term physical con-
sequences of OP and impact on everyday life activity may help
improve compliance and persistence with treatment, as these
impacts may be more salient to patients than fracture incidence.
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